Blood pressure medication improves Covid-19 survival rates

Published by  Communications

On 24th Aug 2020

Manometer to measure blood pressure, stethoscope and blood pressure tablets

Medication for high blood pressure could improve Covid-19 survival rates and reduce the severity of infection - according to new research from the University of East Anglia.

Researchers studied 28,000 patients taking antihypertensives - a class of drugs that are used to treat hypertension (high blood pressure).

They found that the risk of severe Covid-19 illness and death was reduced for patients with high blood pressure who were taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB).

Lead researcher Dr Vassilios Vassiliou, from UEA’s Norwich Medical School, said: “We know that patients with cardiovascular diseases are at particular risk of severe Covid-19 infection. But at the start of the pandemic, there was concern that specific medications for high blood pressure could be linked with worse outcomes for Covid-19 patients.

“We wanted to find out what the impact of these medications is for people with Covid-19.

“We therefore studied the outcomes for patients taking antihypertensives – looking particularly at what we call ‘critical’ outcomes such as being admitted to intensive care or being put on a ventilator, and death.”

The research was led by UEA in collaboration with the Norfolk and Norwich University Hospital.

The team analysed data from 19 studies related to Covid-19 and ACEi and ARB medications. The meta-analysis involved more than 28,000 patients and is the largest and most detailed such study to date.

They compared data from Covid-19 patients who were taking ACEi or ARB medications with those who were not – focusing on whether they experienced ‘critical’ events (admission to intensive care and invasive or non-invasive ventilation) and death.

Dr Vassiliou said: “We found that a third of Covid-19 patients with high blood pressure and a quarter of patients overall were taking an ACEi/ARBs. This is likely due to the increasing risk of infection in patients with co-morbidities such as cardiovascular diseases, hypertension and diabetes.

“But the really important thing that we showed was that there is no evidence that these medications might increase the severity of Covid-19 or risk of death.

“On the contrary, we found that there was a significantly lower risk of death and critical outcomes, so they might in fact have a protective role - particularly in patients with hypertension.

“Covid-19 patients with high blood pressure who were taking ACEi/ARB medications were 0.67 times less likely to have a critical or fatal outcome than those not taking these medications.

“As the world braces itself for a potential second wave of the infection, it is particularly important that we understand the impact that these medications have in Covid-19 patients.

“Our research provides substantial evidence to recommend continued use of these medications if the patients were taking them already.

“However, we are not able to address whether starting such tablets acutely in patients with Covid-19 might improve their prognosis, as the mechanism of action might be different,” he added.

Effect of Renin-Angiotensin-Aldosterone System inhibitors in patients with COVID-19: a systematic review and meta-analysis of 28,872 patients’ is published in the journal Current Atherosclerosis Reports on August 24, 2020.

Latest News

 
The Norwich market.
30 Sep 2022

Brandland Event

Norwich’s prestige as a world-leading centre for brands will be celebrated in a city centre exhibition later this month.

Read more >
 
A young girl using a mobile phone.
30 Sep 2022

Collective effort needed to help children thrive following exposure to online risks

Helping children become more ‘digitally resilient’ needs to be a collective effort if they are to learn how to “thrive online”, according to new research led by...

Read more >
 
Night-time traffic in the UK.
29 Sep 2022

Slowing city traffic cut road deaths by a quarter, study shows

Restricting a city’s speed limit to 20mph reduced road deaths by almost a quarter and serious injuries by a third, according to new research involving UEA.

Read more >
 
An indigenous man stands in front of a camera.
29 Sep 2022

Report calls for Indigenous Peoples’ knowledge to be included in climate policy

A new report highlights how recognising Indigenous Peoples’ and local communities’ knowledge systems could do more to address climate change.

Read more >
Are you searching for something?
 
An indigenous man stands in front of a camera.
29 Sep 2022

Report calls for Indigenous Peoples’ knowledge to be included in climate policy

A new report highlights how recognising Indigenous Peoples’ and local communities’ knowledge systems could do more to address climate change.

Read more >
 
A Japanese flame pot.
29 Sep 2022

‘Circles of Stone’ links astonishing prehistoric parallels of Japan and Britain

Read more >
 
An Ethiopian drought.
28 Sep 2022

Rising global temperatures point to widespread drought

Worsening droughts caused by rising global temperatures pose significant risks around the world – according to new research from UEA. 

Read more >
 
Microscope view of the monkeypox virus.
23 Sep 2022

Monkeypox outbreak highlights need for One Health approach to prevent future zoonotic diseases

The outbreak of monkeypox is a warning for the adoption of a preventative, One Health, approach, accoding to research from UEA.

Read more >
 
A man in a consultation with a medical professional.
22 Sep 2022

UEA breakthrough reveals how prostate cancer may begin

Researchers at the University of East Anglia have made an important discovery about how prostate cancer may start to develop.

Read more >
 
23 Sep 2022

UEA teacher education partnership celebrates good Ofsted outcome

The University of East Anglia (UEA) Initial Teacher Education (ITE) partnership has received a ‘good’ rating across the board, following an Ofsted inspection of...

Read more >
 
Baron Guccuck
01 Aug 2022

2022 Clifford Chance Policy Competition Law Excellence Prize

Read more >